Helus Pharma, Inc. (HELP)
10.71
-0.20
(-1.83%)
USD |
NASDAQ |
Oct 29, 16:00
10.60
-0.11
(-1.03%)
After-Hours: 20:00
Helus Pharma Market Cap : 663.85M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 676.25M |
| October 27, 2026 | 652.07M |
| October 26, 2026 | 642.16M |
| October 23, 2026 | 631.62M |
| October 22, 2026 | 650.83M |
| October 21, 2026 | 668.19M |
| October 20, 2026 | 678.11M |
| October 19, 2026 | 662.61M |
| October 16, 2026 | 653.93M |
| October 15, 2026 | 684.92M |
| October 14, 2026 | 643.40M |
| October 13, 2026 | 650.83M |
| October 12, 2026 | 683.68M |
| October 09, 2026 | 731.41M |
| October 08, 2026 | 664.47M |
| October 07, 2026 | 651.45M |
| October 06, 2026 | 666.95M |
| October 05, 2026 | 707.86M |
| October 02, 2026 | 725.21M |
| October 01, 2026 | 738.23M |
| September 30, 2026 | 761.78M |
| September 29, 2026 | 787.20M |
| September 28, 2026 | 780.38M |
| September 25, 2026 | 781.62M |
| September 24, 2026 | 780.38M |
| Date | Value |
|---|---|
| September 23, 2026 | 807.03M |
| September 22, 2026 | 849.80M |
| September 21, 2026 | 846.70M |
| September 18, 2026 | 766.74M |
| September 17, 2026 | 869.02M |
| September 16, 2026 | 834.93M |
| September 15, 2026 | 813.23M |
| September 14, 2026 | 843.60M |
| September 11, 2026 | 803.93M |
| September 10, 2026 | 795.88M |
| September 09, 2026 | 847.94M |
| September 08, 2026 | 767.98M |
| September 04, 2026 | 757.45M |
| September 03, 2026 | 729.55M |
| September 02, 2026 | 740.71M |
| September 01, 2026 | 719.02M |
| August 31, 2026 | 728.93M |
| August 28, 2026 | 754.97M |
| August 27, 2026 | 820.67M |
| August 26, 2026 | 844.84M |
| August 25, 2026 | 866.85M |
| August 24, 2026 | 807.03M |
| August 21, 2026 | 780.38M |
| August 20, 2026 | 772.94M |
| August 19, 2026 | 730.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 8.703M |
| NervGen Pharma Corp. | 154.30M |
| Milestone Pharmaceuticals, Inc. | 97.31M |
| Appili Therapeutics, Inc. | 0.9001M |
| Clearmind Medicine, Inc. | 1.580M |
Market Cap Related Metrics
| Price to Book Value | 2.742 |
| Price | 10.71 |
| Earnings Yield | -39.64% |